Skip to content

Comparison Between the Efficacy of Ultrasound-guided Erector Spinae Plane Block and Conventional Treatment for Pain Management in Patients With Post-herpetic Neuralgia

Comparison Between the Efficacy of Ultrasound-guided Erector Spinae Plane Block and Conventional Treatment for Pain Management in Patients With Post-herpetic Neuralgia

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07256145
Enrollment
60
Registered
2025-12-01
Start date
2025-08-01
Completion date
2026-03-01
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Herpetic Neuralgia

Brief summary

The present study aims to evaluate the efficacy of ultrasound-guided erector spinae plane block with steroids to relieve pain in cases of post-herpetic neuralgia, patient satisfaction, and record any complications post-injection.

Detailed description

The current study will be conducted as a single-blinded prospective randomized controlled study to evaluate the efficacy of ultrasound-guided erector spinae plane block with steroids to relieve pain in cases of post-herpetic neuralgia. All patients will be evaluated by: * Full history taking: including age, sex, presence of co-morbid conditions as well as the presenting complaint. * Clinical examination and routine lab investigations that include: * Complete blood count (CBC). * Fasting blood glucose (FBG). * Coagulation profile (bleeding time, prothrombin time, prothrombin activity, international normalized ratio). Measurements: Patients will be followed up at 24 hours, 1 week, and 6 weeks after injection. The following measurements will be recorded: 1. Pain will be assessed pre- and post-injection using VAS score at 24 hours, 1 week, and 6 weeks post-injection. 2. Need for analgesic intake post-injection will be assessed at the follow-up periods. 3. Patient satisfaction using the SAPS score. 4. Complications post-injection as pain, irritation or infection will be assessed.

Interventions

PROCEDUREerector spinae plane block

erector spinae plane block with steroids

Sponsors

Alexandria University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients with post-herpetic neuralgia not responding to medical treatment.

Exclusion criteria

\- 1- Patient refusal 2- Age less than 20 years or older than 70 years. 3- Systemic Infection. 4-Patients with dementia or other diseases that could have impaired their memory or cognitive function. 5- Immunocompromised patients, severe osteoporosis, and uncontrolled diabetes mellitus.

Design outcomes

Primary

MeasureTime frameDescription
Evaluate the efficacy of ultrasound-guided erector spinae plane block with steroids to relieve pain in cases of post-herpetic neuralgia6 weeksby VAS score

Secondary

MeasureTime frameDescription
Patient satisfaction6 weeksSAPS score
Complications6 weeksAs pain, irritation or infection

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026